Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Alexanian

Showing results (111-120 of 196) with videos related to

Pageof 20
Sort By:
Neurorehabilitation and Neural Repair|August 17, 2011
Transplanted neurally modified bone marrow-derived mesenchymal stem cells promote tissue protection and locomotor recovery in spinal cord injured ratsArshak R Alexanian, Michael G Fehlings, Zhiying Zhang, et al.
British Journal of Haematology|August 1, 1994
Intensive chemotherapy with blood progenitor transplantation for primary resistant multiple myelomaM A Dimopoulos, J Hester, Y Huh, et al.
Annals of Internal Medicine|April 1, 1972
Bone healing in multiple myeloma with melphalan chemotherapyL H Rodriguez, J B Finkelstein, C C Shullenberger, et al.
American Journal of Hematology|August 1, 1993
Primary treatment with 2-chlorodeoxyadenosine of low grade lymphomas that produce IgG or IgA immunoglobulinM A Dimopoulos, D M Weber, E E Estey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1992
Curability of solitary bone plasmacytomaM A Dimopoulos, J Goldstein, L Fuller, et al.
American Journal of Hematology|November 14, 2000
Randomized trial of alpha-interferon or dexamethasone as maintenance treatment for multiple myelomaR Alexanian, D Weber, M Dimopoulos, et al.
Blood|September 15, 1992
2-Chlorodeoxyadenosine in the treatment of multiple myelomaM A Dimopoulos, H M Kantarjian, E H Estey, et al.
Blood|December 15, 1994
Early myeloablative therapy for multiple myelomaR Alexanian, M A Dimopoulos, J Hester, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|November 1, 1974
Cell-mediated immunity to plasma cell myeloma: specific inhibition by a serum factor adhering to effector lymphocytesG M Mavligit, J U Gutterman, E M Hersh, et al.
Medical and Pediatric Oncology|January 1, 1977
Clinical evaluation of AsaleyG P Bodey, J A Gottlieb, M A Burgess, et al.
Pageof 20

Showing results (111-120 of 196) with videos related to

Sort By:
Pageof 20
Neurorehabilitation and Neural Repair|August 17, 2011
Transplanted neurally modified bone marrow-derived mesenchymal stem cells promote tissue protection and locomotor recovery in spinal cord injured ratsArshak R Alexanian, Michael G Fehlings, Zhiying Zhang, et al.
British Journal of Haematology|August 1, 1994
Intensive chemotherapy with blood progenitor transplantation for primary resistant multiple myelomaM A Dimopoulos, J Hester, Y Huh, et al.
Annals of Internal Medicine|April 1, 1972
Bone healing in multiple myeloma with melphalan chemotherapyL H Rodriguez, J B Finkelstein, C C Shullenberger, et al.
American Journal of Hematology|August 1, 1993
Primary treatment with 2-chlorodeoxyadenosine of low grade lymphomas that produce IgG or IgA immunoglobulinM A Dimopoulos, D M Weber, E E Estey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1992
Curability of solitary bone plasmacytomaM A Dimopoulos, J Goldstein, L Fuller, et al.
American Journal of Hematology|November 14, 2000
Randomized trial of alpha-interferon or dexamethasone as maintenance treatment for multiple myelomaR Alexanian, D Weber, M Dimopoulos, et al.
Blood|September 15, 1992
2-Chlorodeoxyadenosine in the treatment of multiple myelomaM A Dimopoulos, H M Kantarjian, E H Estey, et al.
Blood|December 15, 1994
Early myeloablative therapy for multiple myelomaR Alexanian, M A Dimopoulos, J Hester, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|November 1, 1974
Cell-mediated immunity to plasma cell myeloma: specific inhibition by a serum factor adhering to effector lymphocytesG M Mavligit, J U Gutterman, E M Hersh, et al.
Medical and Pediatric Oncology|January 1, 1977
Clinical evaluation of AsaleyG P Bodey, J A Gottlieb, M A Burgess, et al.
Pageof 20